glp 1 and hypertension Exploring the therapeutic potential of GLP-1 receptor agonists in pulmonary arterial GLP-1R and Diabetes
Description
In both patient populations with pre-existing cardiovascular disease, DPP-4 inhibitors are recommended as one possible third-line therapy besides SGLT-2 inhibitors, thiazolidinediones, or insulin, when therapeutic goals are not met with the previous dual combination
The vanilla base is warm and comforting, the berries add brightness, and the chocolate is indulgent
Although they appropriately used inverse probability of treatment weighting to control for confounding, this approach does not ensure clinical equipoise, limiting causal interpretation because the comparison includes patients who may never have been appropriate candidates for treatment
One of the most common concerns providers are hearing from patients after major GLP-1-assisted weight loss is loose, sagging skin, particularly around the abdomen, shared Brooke French, MD, from CU Medicine Cosmetic Surgery CU Anschutz Health and Wellness Center
Deng, F
doi: 10.1038/s44324-025-00054-5
